Boothbay Fund Management’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-76,975	Closed	-$1.51M	–	1323
2025 Q1	$1.51M	Sell	76,975 -27,915	-27%	-$549K	0.04%	393
2024 Q4	$2.36M	Sell	104,890 -27,943	-21%	-$629K	0.06%	332
2024 Q3	$3.39M	Sell	132,833 -23,129	-15%	-$591K	0.08%	289
2024 Q2	$3.64M	Buy	+155,962	New	+$3.64M	0.09%	268